What will you learn?
High-throughput sequencing data improves discovery of novel therapeutic antibodies. However, getting from millions of sequences to a diverse set of developable antibodies with the right therapeutic properties can be incredibly challenging, time-consuming, and requires significant software and computational resources. In this session, you will learn how to:
- Parse through large pools of antibody candidates generated by high-throughput sequencing
- Integrate prediction of exposed liabilities into seamless workflows
- Use all assay data and in-silico predictions to select the best antibody candidates